Proposal for a New Histopathological Classification of the Carcinomas of the Nasopharynx-Reference-Cited by-同舟云学术

Proposal for a New Histopathological Classification of the Carcinomas of the Nasopharynx

Published:1978-10 Issue:5 Volume:64 Page:513-518
ISSN:0300-8916
Container-title:Tumori Journal
language:en
Short-container-title:Tumori

Author:

Micheau Christian¹,Rilke Franco²,Pilotti Silvana²

Affiliation:

1. Département d'Anatomie Pathologique, Institut Gustave-Roussy, 94800 Villejuif, France

2. Division of Anatomical Pathology and Cytology, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan

Abstract

A new classification scheme for malignant tumors of the nasopharynx is proposed in which the undifferentiated carcinoma of nasopharyngeal types as a prominent position. This term replaces the previous obsolete term lymphoepithelioma on the basis of its clinicopathologic identity, its separation from squamous cell carcinoma, and its potential origin from anatomical areas other than the nasopharynx.

Publisher

SAGE Publications

Subject

Cancer Research,Oncology,General Medicine

Link

http://journals.sagepub.com/doi/pdf/10.1177/030089167806400509

Reference17 articles.

1. Tumors of the nasopharynx in Tunisia.An anatomic and clinical study based on 143 cases

2. Malignant Tumors of the Nasopharynx

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiomics for Predicting Response of Neoadjuvant Chemotherapy in Nasopharyngeal Carcinoma: A Systematic Review and Meta-Analysis;Frontiers in Oncology;2022-05-04

2. Exosomal HMGA2 protein from EBV-positive NPC cells destroys vascular endothelial barriers and induces endothelial-to-mesenchymal transition to promote metastasis;Cancer Gene Therapy;2022-04-06

3. Nasopharyngeal Carcinoma;Pediatric Oncology;2022

4. Epstein Barr Virus: Development of Vaccines and Immune Cell Therapy for EBV-Associated Diseases;Frontiers in Immunology;2021-10-08

Surgical Treatment Outcomes of Spinal Metastases of Nasopharyngeal Carcinoma: The First Report of 30 Patients from a Single Center

;Cancer Management and Research;2020-08